Lenoss Medical
PrivateLast Round
Debt
Mar 17, 2026
Total Funding Raised
$11.3M
Company Overview
Lenoss Medical, Inc. is a medical device company that has developed the OsteoPearl VBA System, a biologic, cement-free technology for treating vertebral compression fractures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lenoss Medical Comps
Public and private peers based on sector, stage, and business model.
Lenoss Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 17, 2026 | ||||
| Series A | May 9, 2024 | ||||
| Seed | May 5, 2021 |
Lenoss Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vodia Capital | Series A |
| Cherrystone Angel Group | Series A, Seed |
| Magpie MedTech Ventures | Debt |
| Beacon Angels | Seed, Debt |
| Walnut Ventures | Seed |
| Highpoint Ventures | Debt |
| RightHill Ventures | Series A, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Raised $6M in debt financing.
Lenoss Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lenoss Medical's valuation, stock price, and market status.